Potential involvement of Egr1 (early growth response 1) gene in mediation of alveolarization and lung growth

J. C. Wolff, J. Wilhelm, L. Fink, U. Seay, A. Zakrzewicz, O. Eickelberg, W. Seeger, R. Voswinckel (Giessen, Germany)

Source: Annual Congress 2007 - Novel genetic markers in pathology
Session: Novel genetic markers in pathology
Session type: Electronic Poster Discussion
Number: 3212

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. C. Wolff, J. Wilhelm, L. Fink, U. Seay, A. Zakrzewicz, O. Eickelberg, W. Seeger, R. Voswinckel (Giessen, Germany). Potential involvement of Egr1 (early growth response 1) gene in mediation of alveolarization and lung growth. Eur Respir J 2007; 30: Suppl. 51, 3212

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Gene expression screening reveals Egr1 gene to be involved in postnatal as well as post-pneumonectomy lung growth
Source: Annual Congress 2008 - Discovery of novel targets in lung disease by means of functional genomics
Year: 2008

Krüppel-like factor 4 (Klf4) is a novel regulator of neonatal lung fibroblast homeostasis and reduced in hyperoxia-induced lung injury
Source: International Congress 2018 – Molecular and cellular determinants of the developing lung
Year: 2018

Cell specific gene transfer of hepatocyte growth factor reduces bleomycin-induced lung fibrosis by inhibition of partial EMT
Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon
Year: 2008

Early growth response gene expression in neutrophils
Source: Eur Respir J 2004; 24: Suppl. 48, 551s
Year: 2004

Haemophilus influenzae (NTHi) up-regulates acute inflammation in human lung tissue and causes downregulation of transforming growth factor-beta (TGF-beta) – A possible role of NTHi in remodeling processes in human lung tissue
Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease
Year: 2010

Inhibition of insulin-like growth factor type I (IGF-I) gene in A549 human lung cancer cell line enhances cell apoptosis and causes phenotype changes relevant to increased tumor susceptibility to immune system
Source: Eur Respir J 2007; 30: Suppl. 51, 715s
Year: 2007

Increased binding activity of hypoxia inducible factor (HIF)-1α to vascular endothelial growth factor (VEGF) promoter region mediates enhanced vascular permeability in the lung of cystic fibrosis (CF) patients
Source: Eur Respir J 2003; 22: Suppl. 45, 173s
Year: 2003

YI01 - Follistatin-like 1: a crucial factor in lung development and a novel regulator of airway remodelling
Source: Lung Science Conference 2012 - Rebuilding a diseased lung: Repair and regeneration
Year: 2012

Novel functional role of GH/IGF1 axis in neonatal lung fibroblasts is linked to lung growth after intrauterine growth restriction
Source: International Congress 2017 – Molecular pathways in lung development
Year: 2017

The role of FoxO transcription factors in normal and aberrant late lung development
Source: International Congress 2017 – Molecular pathways in lung development
Year: 2017

Inhibition of hypoxia-induced phenotype alterations through epithelial-mesenchymal transition (EMT) in lung cancer by gene modulation of phosphorylation sites in tumor suppressor PTEN
Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Year: 2011

SiRNA mediated growth factor receptors inhibition in A549 cell model of lung cancer gene therapy: insulin-like growth factor-I receptor (IGF-R1) blockade produces changes that potentially induce anti-tumor immunity
Source: Annual Congress 2008 - Biology in thoracic tumours
Year: 2008


Fibroblast growth factor 9 (FGF9) modulates mesothelial cells plasticity to decrease differentiation and migration in vitro
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016

Expression of vascular endothelial growth factor (VEGF) and its receptors (VEFG-R1-Flt1, VEGF-R2-Flk1) in non small cell lung carcinomas (NSCLC): correlation with lymphangiogenesis and clinical outcome
Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology
Year: 2007


c-Met expression induction in immune cells modulates pulmonary fibrosis progression
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020

A role for the accessory type III transforming growth factor β receptor (Tgfbr3) in lung alveolarisation
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016

VEGF gene polymorphisms are associated with post-natal lung function development
Source: Annual Congress 2011 - Genetics of airway diseases and treatment
Year: 2011


Reduced expression of the transcription factor KLF4 in COPD macrophages is associated with dysfunctional differentiation
Source: International Congress 2017 – Translational studies of lung disease
Year: 2017

VEGF signaling regulates Fgf10 spatial distribution and coordinate early lung epithelial branching morphogenesis
Source: Annual Congress 2008 - Discovery of novel targets in lung disease by means of functional genomics
Year: 2008

Specific plasmids encoding shRNA molecules directed against growth factor receptors in cell proliferation inhibition and induction phenotype changes relevant to enhancement of anti-tumor immunity. Model of human non-small (NSCLC) and small (SCLC) cell lung cancer lines
Source: Annual Congress 2010 - Pathology of lung cancer
Year: 2010